Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Ray-Coquard

Showing results (201-210 of 550) with videos related to

Pageof 55
Sort By:
European Journal of Cancer (Oxford, England : 1990)|November 9, 2016
Current perspectives on recommendations for BRCA genetic testing in ovarian cancer patientsIgnace Vergote, Susana Banerjee, Anne-Marie Gerdes, et al.
Investigational New Drugs|February 12, 2009
Development and validation of a model that predicts early death among cancer patients participating in phase I clinical trials investigating cytotoxicsNicolas Penel, Jean-Pierre Delord, Marie-Edith Bonneterre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
Phase I combination study of trabectedin and doxorubicin in patients with soft-tissue sarcomaJean-Yves Blay, Margaret von Mehren, Brian L Samuels, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for high-grade undifferentiated sarcomas of the uterusPatricia Pautier, Eun Ji Nam, Diane M Provencher, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for cervical adenocarcinomaHiroyuki Fujiwara, Harushige Yokota, Bradley Monk, et al.
ESMO Open|December 2, 2020
First results of the EORTC-SPECTA/Arcagen study exploring the genomics of rare cancers in collaboration with the European reference network EURACANMarie Morfouace, Aleksandra Stevovic, Marie Vinches, et al.
BMC Cancer|February 9, 2017
Treatment patterns and survival in an exhaustive French cohort of pazopanib-eligible patients with metastatic soft tissue sarcoma (STS)Isabelle Ray-Coquard, Olivier Collard, Françoise Ducimetiere, et al.
Bulletin Du Cancer|September 7, 2023
Gynecological carcinosarcomas: Overview and future perspectivesLaetitia Collet, Andrea María González López, Clémence Romeo, et al.
Breast Cancer Research and Treatment|December 25, 2010
Chemotherapy for metastatic breast cancer. Comparison of clinical practice and cost of drugs in two cohorts of patients: 1994-1998 and 2003-2006Guillaume Galy, Sana Intidhar Labidi-Galy, David Perol, et al.
Gynecologic Oncology|May 18, 2011
Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: analysis from the GCIG CALYPSO relapsing ovarian cancer trialFlorence Joly, Isabelle Ray-Coquard, Michel Fabbro, et al.
Pageof 55

Showing results (201-210 of 550) with videos related to

Sort By:
Pageof 55
European Journal of Cancer (Oxford, England : 1990)|November 9, 2016
Current perspectives on recommendations for BRCA genetic testing in ovarian cancer patientsIgnace Vergote, Susana Banerjee, Anne-Marie Gerdes, et al.
Investigational New Drugs|February 12, 2009
Development and validation of a model that predicts early death among cancer patients participating in phase I clinical trials investigating cytotoxicsNicolas Penel, Jean-Pierre Delord, Marie-Edith Bonneterre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
Phase I combination study of trabectedin and doxorubicin in patients with soft-tissue sarcomaJean-Yves Blay, Margaret von Mehren, Brian L Samuels, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for high-grade undifferentiated sarcomas of the uterusPatricia Pautier, Eun Ji Nam, Diane M Provencher, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for cervical adenocarcinomaHiroyuki Fujiwara, Harushige Yokota, Bradley Monk, et al.
ESMO Open|December 2, 2020
First results of the EORTC-SPECTA/Arcagen study exploring the genomics of rare cancers in collaboration with the European reference network EURACANMarie Morfouace, Aleksandra Stevovic, Marie Vinches, et al.
BMC Cancer|February 9, 2017
Treatment patterns and survival in an exhaustive French cohort of pazopanib-eligible patients with metastatic soft tissue sarcoma (STS)Isabelle Ray-Coquard, Olivier Collard, Françoise Ducimetiere, et al.
Bulletin Du Cancer|September 7, 2023
Gynecological carcinosarcomas: Overview and future perspectivesLaetitia Collet, Andrea María González López, Clémence Romeo, et al.
Breast Cancer Research and Treatment|December 25, 2010
Chemotherapy for metastatic breast cancer. Comparison of clinical practice and cost of drugs in two cohorts of patients: 1994-1998 and 2003-2006Guillaume Galy, Sana Intidhar Labidi-Galy, David Perol, et al.
Gynecologic Oncology|May 18, 2011
Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: analysis from the GCIG CALYPSO relapsing ovarian cancer trialFlorence Joly, Isabelle Ray-Coquard, Michel Fabbro, et al.
Pageof 55